Dr. Andrew Lewis, Quotient Sciences’ Chief Scientific Officer, has been recognized by the Controlled Release Society (CRS) as a recipient of the 2024 Distinguished Service Award.
CRS established the award in 1994 to recognize CRS members who have exhibited exceptional commitment and service to the organization. Winners are selected by the CRS Board of Directors, composed of senior leaders and executives from academia and the pharmaceutical and biotech industry. An award ceremony will take place in July at the annual CRS global meeting in Bologna, Italy.
The Distinguished Service Award is not automatically given each year to a CRS member but only in cases where an exceptional member fits the criteria for having given sustained and outstanding service. Several factors determine a person’s eligibility for the award, including the person’s contributions to the development of high-impact, sustainable initiatives for the organization, the understanding and delivery of science and technology to various audiences, and the enhancement of the organization’s global membership and reach.
“Since its inception, the CRS has established itself as a world-leading organization for delivery science, providing forums for collaboration and knowledge sharing that have led to the development of many products that improve the quality of life of people globally,” said Dr. Lewis. “I am honored and humbled to be recognized for my contribution and thank the CRS for this award.”
Dr. Lewis has been a member of CRS for 20 years and has actively contributed to its development on a range of initiatives, including the Membership Committee, Scientific Advisory Board, and two tenures on the Board of Directors as Director-at-Large and most recently as Secretary.
Read the official announcement here.